April 29, 2024
This training is designed to provide pharmacovigilance professionals with advanced knowledge and skills to navigate the evolving landscape of drug safety and regulatory compliance in an increasingly interconnected world. Through the sessions, participants are invited to explore current relevant pharmacovigilance topics.
Discussion of several relevant topics on pharmacovigilance field, namely: Artificial intelligence, computerized systems, quality assurance in ICSR processing, advanced pharmacovigilance requirements and practices, and orphan and biotechnology medicinal products. From cutting-edge technology, regulatory requirements and challenges for specific medicinal products, these topics constitute important challenges for Marketing Authorisation Holders and pharmacovigilance professionals. By fostering collaboration and critical thinking, this training empowers pharmacovigilance professionals to proactively address emerging challenges and drive continuous improvement in drug safety initiatives.
Mariana Rocha - Pharmacovigilance Director, Owlpharma
Jose Alberto Ayala Ortiz - PVpharm CEO, Pharmacovigilance Consultant, QPPV, PV Auditor
Ana Maria Tomé - Consultant (GVP Team), ADAMAS Consulting
Sara França - Pharmacovigilance Manager, Owlpharma
Ricardo Andrade - Owlpharma Managing Director, QPPV, PV auditor
Jan Kolouch - CEO / EU QPPV / Strategic PV Advisor, NextPV Services
An email will be sent confirming your registration and payment details.The registration will not be finalised until payment has been confirmed.
Registration until 17/05/2024:
Registration after 17/05/2024:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Trainee Data
